Association Between Beta-1 and Beta-2 Adrenergic Receptor Polymorphism and Beta-blocker(Bisoprolol) Therapy in Heart Failure.

Trial Profile

Association Between Beta-1 and Beta-2 Adrenergic Receptor Polymorphism and Beta-blocker(Bisoprolol) Therapy in Heart Failure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 May 2012

At a glance

  • Drugs Bisoprolol (Primary)
  • Indications Chronic heart failure
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms ABBA
  • Sponsors Merck KGaA
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Mar 2012 Additional lead trial centre/investigator identified as reported by ClinicalTrials.gov.
    • 06 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top